News

Introducing Butternaise: The Game-Changing Spread for Sizzling Sandwiches

Introducing Butternaise: The Game-Changing Spread for Sizzling Sandwiches

Butternaise: The Ultimate Grilled Cheese Companion

Tillamook County Creamery Association (TCCA) has recently unveiled a remarkable new spread called Butternaise, combining two beloved ingredients: butter and mayonnaise. This unique condiment has sparked interest among food enthusiasts, particularly amidst the ongoing butter versus mayonnaise debate seen across social media platforms.

How Butternaise Came to Be

Born from a collaboration between TCCA and KEWPIE, Butternaise is crafted with Tillamook Extra Creamy Unsalted Butter and KEWPIE Organic Mayonnaise, along with a blend of zesty spices. This thoughtfully designed spread serves as the secret behind the Tillamook Executive Chef Josh Archibald's acclaimed grilled cheese sandwiches. Butternaise is designed to enhance the flavor and texture, making it an indispensable addition to your kitchen.

The Perfect Grilled Cheese Sandwich

To create the ultimate grilled cheese sandwich, the key lies in the choice of ingredients and their application. With Butternaise, you can achieve a beautifully golden crust on your sandwich. Simply lather on this silky spread to your bread of choice for an irresistible combination of flavors. You'll discover a whole new level of gastronomic bliss that you never knew you needed.

Availability and Where to Get It

Butternaise will be available for a limited time starting November 6, exclusively through online sales. You can find it offered at shop.tillamook.com while supplies last. This spread is perfect for those who love crafting gourmet experiences right at home. If you're eager to elevate your grilled cheese game, check out the delicious recipes that will inspire you to get creative in the kitchen.

Visit Tillamook for More Inspiration

Discover a variety of recipes by visiting tillamook.com/recipes. You'll also find inspiration from top chefs as they share their unique takes on grilled cheese. Engage with culinary creators like Owen Han, Toni Chapman, and Chef Tyler Kaminski, who offer tips and tricks for utilizing Butternaise in creative ways. With their expert guidance, you'll be well on your way to mastering the art of the grilled cheese sandwich.

About Tillamook County Creamery Association

Founded in 1909, Tillamook County Creamery Association is a farmer-owned cooperative focused on creating high-quality dairy products. TCCA operates with values emphasizing quality above all else, ensuring that every product—from cheese to ice cream—is crafted with care. Their dedication to delivering real food while impacting the community positively has made them an iconic brand.

About KEWPIE

With its roots tracing back to 1919 in Japan, KEWPIE has built a legacy around producing joyful food. They gained fame with their mayonnaise, which is loved for its creamy texture and rich flavor. Today, KEWPIE’s offerings now include a range of sauces and condiments, enriching the culinary experiences for home cooks and chefs alike across North America.

Frequently Asked Questions

What is Butternaise?

Butternaise is a unique spread made with Tillamook Extra Creamy Unsalted Butter and KEWPIE Organic Mayonnaise, designed specifically for grilled cheese sandwiches.

When will Butternaise be available?

Butternaise will be available starting November 6, but it's only sold online at shop.tillamook.com, so be sure to grab it while supplies last.

How should I use Butternaise?

Simply apply a generous layer of Butternaise to your bread before grilling to achieve a beautifully crispy and golden crust on your grilled cheese sandwich.

Where can I find recipes featuring Butternaise?

You can find a variety of delicious recipes using Butternaise on tillamook.com/recipes, offering plenty of inspiration for your next culinary adventure.

What is the history of Tillamook County Creamery Association?

TCCA was founded in 1909 as a farmer-owned cooperative and has become known for producing high-quality dairy products while maintaining a commitment to community and sustainability.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading